PEGBIO CO-B (02565) announced that it recently received a notice from its cornerstone investor, Benefit Kangrui Pharmaceuticals (Hong Kong) Limited, agreeing not to reduce any holdings of the company's H-shares in any manner from the original lock-up expiration date until December 31, 2025 (extended lock-up period). The company believes this extension demonstrates the cornerstone investor's confidence in PEGBIO CO-B's future prospects, based on its R&D capabilities in advancing technology and significant progress in key clinical milestones. The cornerstone investor will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones.
- Like
- Comment
- Favorite
PEGBIO CO-B (02565): Cornerstone Investor Voluntarily Extends Lock-Up Period
Stock News11-26
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Like
Report
Login to post
No comments yet